| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-12 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.27 | 4e-07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |